Coexisting Molecular Determinants of Acquired Oxaliplatin Resistance in Human Colorectal and Ovarian Cancer Cell Lines

Oxaliplatin (OHP) treatment of colorectal cancer (CRC) frequently leads to resistance. OHP resistance was induced in CRC cell lines LoVo-92 and LoVo-Li and a platinum-sensitive ovarian cancer cell line, A2780, and related to cellular platinum accumulation, platinum-DNA adducts, transporter expressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Noordhuis, Paul, Laan, Adrianus C., van de Born, Kasper, Honeywell, Richard J., Peters, Godefridus J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696456/
https://www.ncbi.nlm.nih.gov/pubmed/31344863
http://dx.doi.org/10.3390/ijms20153619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696456/
https://www.ncbi.nlm.nih.gov/pubmed/31344863
http://dx.doi.org/10.3390/ijms20153619

Ejemplares similares